ABERA BIOSCIENCE AB (8WK) — Tangible Net Worth Ratio

Latest as of March 2026: 92.0%

ABERA BIOSCIENCE AB (8WK) has a Tangible Net Worth Ratio of 92.0% as of March 2026. This metric is calculated by deducting intangible assets (€1.89 Million) from net assets (€23.48 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 8WK net asset momentum to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

92.0%
Tangible equity / total equity

Net Assets (Equity)

€23.48 Million
EUR

Intangible Assets

€1.89 Million
Goodwill, patents, brand value

Total Assets

€31.05 Million
EUR

ABERA BIOSCIENCE AB Tangible Net Worth Ratio (2022–2025)

This chart shows how ABERA BIOSCIENCE AB's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 92.0%, reflecting net assets of €23.48 Million with intangible assets of €1.89 Million EUR. For live market cap and overall valuation, see ABERA BIOSCIENCE AB (8WK) market capitalisation.

Annual Tangible Net Worth Ratio for ABERA BIOSCIENCE AB (2022–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for ABERA BIOSCIENCE AB from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 8WK capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Year Tangible NW Ratio Net Assets (EUR) Intangible Assets Total Assets Change (pp)
2025 90.2% €19.29 Million €1.89 Million €28.57 Million ▲ +12.0 pp
2024 78.2% €8.66 Million €1.89 Million €13.60 Million ▲ +11.6 pp
2023 66.6% €5.66 Million €1.89 Million €9.35 Million ▼ -22.1 pp
2022 88.7% €16.78 Million €1.89 Million €19.57 Million
pp = percentage points